Sodium ferric gluconate complex in hemodialysis patients. Ii. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients

Kidney International

Volumn 63, Issue 1, 2003, Pages 217-224

  Coyne, Daniel W ^{a,b,c,d,e,f,g,h,i,j,k,l}   Adkinson Jr , N Franklin ^{a,b,c,d,e,f,g,h,i,j,k,l}   Nissenson, Allen R ^{a,b,c,d,e,f,g,h,i,j,k,l}   Fishbane, Steven ^{a,b,c,d,e,f,g,h,i,j,k,l}   Agarwal, Rajiv ^{a,b,c,d,e,f,g,h,i,j,k,l}   Eschbach, Joseph W ^{a,b,c,d,e,f,g,h,i,j,k,l}   Michael, Beckie ^{a,b,c,d,e,f,g,h,i,j,k,l}   Folkert, Vaughn ^{a,b,c,d,e,f,g,h,i,j,k,l}   Batlle, Daniel ^{a,b,c,d,e,f,g,h,i,j,k,l}   Trout, J Richard ^{a,b,c,d,e,f,g,h,i,j,k,l}   Dahl, Naomi ^{a,b,c,d,e,f,g,h,i,j,k,l}   Myirski, Pamela ^{a,b,c,d,e,f,g,h,i,j,k,l}   Strobos, Jur ^{a,b,c,d,e,f,g,h,i,j,k,l}   Warnock, David G ^{a,b,c,d,e,f,g,h,i,j,k,l}  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d WINTHROP UNIVERSITY HOSPITAL   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Northwest Kidney Centers   (United States)

^g THOMAS JEFFERSON UNIVERSITY   (United States)

^h ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

ⁱ NORTHWESTERN UNIVERSITY   (United States)

^j Rutgers Cooperative   (United States)

^k Watson Laboratories Inc   (United States)

^l UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

more..

Author keywords

Allergy; Anemia; Drug safety; Hemoglobin; Intravenous iron; Parenteral iron; Renal failure; Tryptase

Indexed keywords

FERRIC GLUCONATE; IRON DEXTRAN; PLACEBO; TRYPTASE;

ADULT; ALLERGIC REACTION; ARTICLE; BRONCHOSPASM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG SENSITIVITY; DRUG TOLERABILITY; ENZYME BLOOD LEVEL; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPOTENSION; IMMUNOREACTIVITY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MAST CELL DEGRANULATION; MULTICENTER STUDY; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL;

EID: 6444245556     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00703.x     Document Type: Article

References (28)

1. Fishbane S, Wagner J: Sodium ferric gluconate complex in the treatment of iron deficiency for patients on dialysis. Am J Kidney Dis 37:879-883, 2001
2. National Kidney Foundation: K/DOQI clinical practice guidelines for anemia of chronic renal disease, 2000. Am J Kidney Dis 37(Supp 1):S182-S238, 2001
3. Macdougall IC, Horl WH, Jacobs C, et al: European best practice guidelines 6-8: Assessing and optimizing iron stores. Nephrol Dial Transplant 15(Suppl 4):20-32, 2000
4. Faich G, Strobos J: Sodium ferric gluconate complex in sucrose: Safer intravenous iron therapy than iron dextrans. Am J Kidney Dis 33:464-470, 1999
5. Fletes R, Lazarus JM, Gage J, Chertow GM: Suspected iron dextran-related adverse drug events in hemodialysis patients. Am J Kidney Dis 37:743-749, 2001
6. Horl WH: Should we still use iron dextran in hemodialysis patients? Am J Kidney Dis 37:859-861, 2001
7. Michael B, Coyne DW, Fishbane S, et al: Sodium ferric gluconate complex in hemodialysis patients: Adverse reactions compared to placebo and iron dextran. Kidney Int 61:1830-1839, 2002
8. Schwartz LB, Bradford TR, Rouse C, et al: Development of a new, more sensitive immunoassay for human tryptase: Use in systemic anaphylaxis. J Clin Immunol 14:190-204, 1994
9. Schwartz LB, Yunginger JW, Miller J, et al: Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 83:1551-1555, 1989
10. Schwartz LB: Laboratory assessment of immediate hypersensitivity and anaphylaxis: Utilization of tryptase as a marker of mast cell dependent events, in Immunology and Allergy Clinics of North America: Diagnostic Laboratory Immunology, edited by Huston D, Philadelphia, Saunders, 1994, pp 339-350
11. U.S. Food and Drug Administration: Approval Package for 21-135. Venofer (Iron Sucrose Injection). Memorandum on Pre-45 Day Filing Meeting for NDA 21-135 for Iron Sucrose Injection. Attachment 1. p. 44. Available on request from Freedom of Information Officer, HFD-205, Center for Drug Evaluation and Research. 5600 Fishers Lane, Rockville, MD 20857, 2000
12. Bailey G, Strub RL, Klein RC, Salvaggio J: Dextran-induced anaphylaxis. JAMA 200:889-891, 1967
13. Ring J, Messmer K: Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1:466-469, 1977
14. Ring J: Anaphylactoid reactions to intravenous solutions used for volume substitution. Clin Rev Allergy 9:397-414, 1991
15. Paull J: A prospective study of dextran-induced anaphylactoid reactions in 5745 patients. Anaesth Intensive Care 15:163-167, 1987
16. Vervloet D, Senft M, Dugue P, et al: Anaphylactic reactions to modified fluid gelatins. J Allergy Clin Immunol 71:535-540, 1983
17. Richter W: Hapten inhibition of passive antidextran dextran anaphylaxis in guinea pigs. Role of molecular size in anaphylactogenicity and precipitability of dextran fractions. Int Arch Allergy Appl Immunol 41:826-844, 1971
18. Ljungstrom KG, Renck H, Strandberg K, et al: Adverse reactions to dextran in Sweden 1970-1979. Acta Chir Scand 149:253-262, 1983
19. Hedin H, Richter W, Ring J: Dextran-induced anaphylactoid reactions in man: Role of dextran reactive antibodies. Int Arch Allergy Appl Immunol 52:145-159, 1976
20. Renck H, Ljungstrom KG, Hedin H, Richter W: Prevention of dextran-induced anaphylactic reactions by hapten inhibition. III. A Scandinavian multicenter study on the effects of 20 ml dextran 1, 15%, administered before dextran 70 or dextran 40. Acta Chir Scand 149:355-360, 1983
21. Pradal M, Vervloet D: Drug reactions, in Allergy and Allergic Diseases, edited by KAY A, Oxford, Blackwell Science, 1997, pp 1671-1692
22. Adkinson N: Drug allergy, in Allergy: Principles and Practice (5th Ed), edited by Middelton E, St. Louis, Mosby, 1998, pp 1212-1224
23. Lieberman P: Anaphylactoid reactions to radiocontrast material. Clin Rev Allergy 9:319-338, 1991
24. Lichtenstein LM, MacGlashan DW Jr: The concept of basophil releasability. J Allergy Clin Immunol 77:291-294, 1986
25. Asero R: Detection of patients with multiple drug allergy syndrome by elective tolerance tests. Ann Allergy Asthma Immunol 80:185-188, 1998
26. Sullivan TJ: Management of patients allergic to antimicrobial drugs. Allergy Proc 12:361-364, 1991
27. Siegel S: Multiple chemical sensitivity as a conditional response. Toxicol Ind Health 15:323-330, 1999
28. Schwartz LB, Metcalfe DD, Miller JS, et al: Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 316:1622-1626, 1987